Image via Cloud DX
(Source: Cloud DX.)
  • Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000
  • The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture
  • The debentures will bear 18 per cent interest per annum
  • Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care
  • Cloud DX Inc. (CDX) opened trading at C$0.155

Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000.

The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture.

The debentures will mature 12 months after they’re issued and shall bear 18 per cent interest per annum. The principal amount of the debenture is convertible into common shares at a conversion price of $0.15 per share any time prior to the maturity date.

Net proceeds will be used for inventory and general working capital purposes.

The offering is expected to occur in one or more tranches, with the first tranche scheduled to close on or about June 24, 2022.

The debentures and any securities issued upon conversion will be subject to a statutory four-month hold period. The offering is subject to TSX Venture Exchange approval.

Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care.

Cloud DX Inc. (CDX) opened trading at C$0.155.

More From The Market Online

Small-cap Canadian healthcare firm expands AI-screening at home and abroad

Diagnos (TSXV:ADK) uses AI through its CARA platform to help detect eye diseases like diabetic retinopathy & age-related macular degeneration

The 5-Minute Investor Podcast, Ep. 85: Standout AI healthcare stocks

Listen to episode 85 of The 5-Minute Investor Podcast, featuring analysis on AI healthcare stocks Diagnos and CeriBell.

This healthtech company improves neurological care with AI

CeriBell is a healthtech company applying AI to neurological critical care, vastly improving diagnoses versus legacy technology.